Baltimore SunNovavax's Ebola vaccine shows promise in early-stage trialReutersNovavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults. The Ebola GP Vaccine was well tolerated and elicited very high Ebola antibody responses ...Novavax's Ebola vaccine shows human immune responseBaltimore SunDoes Novavax Have the Answer for Ebola in New Trial?24/7 Wall St.Novavax Gains as Ebola Vaccine Shows Human Immune ResponseBloombergCNBC -MarketWatchall 15 news articles »
Novavax's Ebola vaccine shows promise in early
Rating: 4.5
Diposkan Oleh: Unknown
